[125I]RTI-55: a potent ligand for dopamine transporters.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  European Journal of Pharmacology

• Publication date

  1991-02-26

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-2999(91)90137-FPMID 2060590
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New, potent cocaine analogs: ligand binding and transport studies in rat striatum.

  1990cited by this paper
• [3H]WIN 35,065–2: A Ligand for Cocaine Receptors in Striatum

  1990cited by this paper
• Cocaine receptors labeled by [3H]2 beta-carbomethoxy-3 beta-(4-fluorophenyl)tropane.

  1989cited by this paper
• Compounds affecting the central nervous system. 4. 3 Beta-phenyltropane-2-carboxylic esters and analogs.

  1973cited by this paper

• The compulsion zone explains the self-administration of cocaine, RTI-55 and bupropion in rats.

  2021cites this paper
• Dopamine transporter (DAT) imaging in Parkinson’s disease and related disorders

  2021cites this paper
• Brain uptake and metabolism of the endocannabinoid anandamide labeled in either the arachidonoyl or ethanolamine moiety.

  2017cites this paper
• Drug Delivery Systems for Imaging and Therapy of Parkinson's Disease

  2016cites this paper
• Increased Sensitivity to Cocaine Self-Administration in HIV-1 Transgenic Rats is Associated with Changes in Striatal Dopamine Transporter Binding

  2015influential citation
• Direct targeted quantitative molecular imaging of neurotransmitters in brain tissue sections.

  2014cites this paper
• Changes in dopamine transporter binding in nucleus accumbens following chronic self‐administration cocaine: Heroin combinations

  2014cites this paper
• (11) C and (18) F PET radioligands for the serotonin transporter (SERT).

  2013cites this paper
• Differential serotonin transport is linked to the rh5-HTTLPR in peripheral blood cells

  2012cites this paper
• Thalamic ¹²³I FP-CIT uptake in a patient with clinical diagnosis of Parkinson's disease and depression.

  2012cites this paper
• Synthesis, fluorine-18 radiolabeling, and biological evaluation of N-((E)-4-fluorobut-2-en-1-yl)-2beta-carbomethoxy-3beta-(4'-halophenyl)nortropanes: candidate radioligands for in vivo imaging of the brain dopamine transporter with positron emission tomography.

  2010cites this paper
• Dopamine transporter binding in rat striatum: a comparison of [O-methyl-11C]beta-CFT and [N-methyl-11C]beta-CFT.

  2009cites this paper
• PET and SPECT in the Evaluation of Patients with Central Motor Disorders

  2009cites this paper
• 1-Naphthyl and 4-indolyl arylalkylamines as selective monoamine reuptake inhibitors.

  2009cites this paper
• Fluorine-18 Radiolabeled PET Tracers for Imaging Monoamine Transporters: Dopamine, Serotonin, and Norepinephrine.

  2009cites this paper
• PE2I: A Radiopharmaceutical for In vivo Exploration of the Dopamine Transporter

  2008influential citation
• DAT, Dopamine Transporter

  2008cites this paper
• Synthesis, radiosynthesis, and biological evaluation of fluorine-18-labeled 2beta-carbo(fluoroalkoxy)-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.

  2008cites this paper
• Small molecule receptors as imaging targets.

  2008cites this paper
• Photolabeling of the human dopamine transporter and the reactivity of aryl azides with amino acid analogs

  2008cites this paper
• In Vivo Characterization of a Novel Phenylisothiocyanate Tropane Analog at Monoamine Transporters in Rat Brain

  2008cites this paper
• PrinciplesBrain Single-Photon Emission CT Physics

  2008cites this paper
• Brain Single-Photon Emission CT Physics Principles

  2008cites this paper
• Irreversible binding of a novel phenylisothiocyanate tropane analog to monoamine transporters in rat brain.

  2007cites this paper
• Positron Emission Tomography in Patients With Central Motor Disorders and in Evaluation of Brain and Other Tumors

  2007cites this paper
• Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects

  2006cites this paper
• Topography of cerebral monoamine transporter availability in families with SCA2 mutations: a voxel-wise [123I]β-CIT SPECT analysis

  2006cites this paper
• SPECT imaging of dopamine and serotonin transporters with [123I]β-CIT. Binding kinetics in the human brain

  2005cites this paper
• Neuroimaging in Parkinson’s Disease

  2005cites this paper
• Targeted screening for biogenic amine transporters: potential applications for natural products.

  2005cites this paper
• The interaction of methylphenidate and benztropine with the dopamine transporter is different than other substrates and ligands.

  2005cites this paper
• Comparison of [123I]ß-CIT and [123I]IPCIT as single-photon emission tomography radiotracers for the dopamine transporter in nonhuman primates

  2005cites this paper
• Striatal dopamine transporter availability with [123I]β-CIT SPECT is unrelated to gender or menstrual cycle

  2005cites this paper
• Cocaine binding sites in fetal rat brain: implications for prenatal cocaine action

  2005cites this paper
• Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease.

  2005cites this paper
• PET and SPECT exploration of central monoaminergic transporters for the development of new drugs and treatments in brain disorders.

  2005cites this paper
• Primate Brain Using Single Photon Emission Computed Tomography

  2004cites this paper
• AB INITIO MO CALCULATION STUDIES FOR SEVERAL NOVEL ENTRIES TO TROPANE COMPOUNDS

  2004cites this paper
• Two- and three dimensional combinatorial chemistry from multicomponent Grignard reagents.

  2004cites this paper
• Imaging Dopamine Transporters in Parkinson’s Disease and Other Movement Disorders

  2003cites this paper
• Designer drugs: how dangerous are they?

  2003influential citation
• Identification of dopamine transporter in bovine pineal gland using [3H]GBR 12935

  2003cites this paper
• Single-photon emission tomography and dopamine transporter imaging in Parkinson's disease.

  2003cites this paper
• Dopamine transporter: Basic aspects and neuroimaging

  2003cites this paper
• Studies of the biogenic amine transporters. VIII: Identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding

  2002influential citation
• Rezeptorliganden für die Bildgebung der Neurotransmission mit SPECT und PET

  2002cites this paper
• Pharmacological characterisation of (E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-methylphenyl)nortropane (PE2I) binding to the rat neuronal dopamine transporter expressed in COS cells.

  2002cites this paper
• Sex differences in [123I]β‐CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers

  2001cites this paper
• [125 I]3β‐(4‐ethyl‐3‐iodophenyl)nortropane‐2β‐carboxylic acid methyl ester ([125I]EINT): A potent and selective radioligand for the brain serotonin transporter

  2001cites this paper
• Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach

  2001cites this paper
• [11C,127I] Altropane: A highly selective ligand for PET imaging of dopamine transporter sites

  2001cites this paper
• Locomotor stimulant effects of novel phenyltropanes in the mouse.

  2001cites this paper
• Synthesis and preliminary characterization of a high‐affinity novel radioligand for the dopamine transporter

  2001cites this paper
• Sensitivity of binding of high‐affinity dopamine receptor radioligands to increased synaptic dopamine

  2000cites this paper
• Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [123I]β-CIT

  2000cites this paper
• Dopamine transporter binding in Gilles de la Tourette syndrome

  2000cites this paper
• Characterization of a Tropane Radioligand, [ 3 H]2 b -Propanoyl-3 b -(4-tolyl) Tropane ([ 3 H]PTT), for Dopamine Transport Sites in Rat Brain 1

  2000influential citation
• [123I] β-CIT binding and SPET compared with clinical diagnosis in parkinsonism

  2000cites this paper
• 123I.-@3-CIT SPECT:Binding Kinetics and Effects of Normal Aging

  2000cites this paper
• Characterization of a tropane radioligand, [(3)H]2beta-propanoyl-3beta-(4-tolyl) tropane ([(3)H]PTT), for dopamine transport sites in rat brain.

  2000cites this paper
• Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT.

  2000cites this paper
• [123I]β‐CIT spect in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration

  2000cites this paper
• Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.

  2000cites this paper
• Characterization of a Tropane Radioligand, [3H]2β-Propanoyl-3β-(4-tolyl) Tropane ([3H]PTT), for Dopamine Transport Sites in Rat Brain

  2000cites this paper
• Fluorine‐18‐labeled tropane analogs for PET imaging studies of the dopamine transporter

  2000cites this paper
• [123I] beta-CIT binding and SPET compared with clinical diagnosis in parkinsonism.

  2000cites this paper
• Pharmacological characterization of (E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-methylphenyl)n ortropane as a selective and potent inhibitor of the neuronal dopamine transporter.

  1999cites this paper
• Pharmacological Characterization of (E)-N-(3-iodoprop-2-enyl)-2β-Carbomethoxy-3β-(4′-methylphenyl)nortropane as a Selective and Potent Inhibitor of the Neuronal Dopamine Transporter

  1999cites this paper
• Non‐amine dopamine transporter probe [3H]tropoxene distributes to dopamine‐rich regions of monkey brain

  1999cites this paper
• Effects of scatter and attenuation correction on quantitative analysis of beta-CIT brain SPET.

  1999cites this paper
• [3H]beta-CIT: a radioligand for dopamine transporters in rat brain tissue.

  1999cites this paper
• [3H]β-CIT: a radioligand for dopamine transporters in rat brain tissue

  1999cites this paper
• PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter.

  1999cites this paper
• A selective radiobrominated cocaine analogue for imaging of dopamine uptake sites: pharmacological evaluation and PET experiments.

  1999cites this paper
• Regulation of Rat Dopamine Transporter mRNA and Protein by Chronic Cocaine Administration

  1999cites this paper
• Dopamine transporter loss and clinical changes in MPTP-lesioned primates.

  1999cites this paper
• Exploration of the dopamine transporter: in vitro and in vivo characterization of a high-affinity and high-specificity iodinated tropane derivative (E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-m ethylph enyl)nortropane (PE2I).

  1998cites this paper
• Studies of the biogenic amine transporters. VII. Characterization of a novel cocaine binding site identified with [125I]RTI‐55 in membranes prepared from human, monkey and guinea pig caudate

  1998cites this paper
• Fentanyl decreases β‐CIT binding to the dopamine transporter

  1998cites this paper
• In vivo generation of chimeras.

  1998cites this paper
• [123I]beta-CIT and SPECT in essential tremor and Parkinson's disease.

  1998cites this paper
• [123I]β-CIT and SPECT in essential tremor and Parkinson's disease

  1998cites this paper
• Rapid detection of Parkinson's disease by SPECT with altropane: A selective ligand for dopamine transporters

  1998cites this paper
• Biodistribution and dosimetry of TRODAT-1: a technetium-99m tropane for imaging dopamine transporters.

  1998cites this paper
• Novel rhenium complexes derived from alpha-tropanol as potential ligands for the dopamine transporter.

  1998cites this paper
• Long-acting blockade of biogenic amine transporters in rat brain by administration of the potent novel tropane 2beta-propanoyl-3beta-(2-Naphthyl)-tropane.

  1998cites this paper
• Toxicity, mutagenicity, and behavioral effects of beta-CIT, a ligand for dopamine transporter exploration by SPECT.

  1998cites this paper
• Assessment of affinities of beta-CIT, beta-CIT-FE, and beta-CIT-FP for monoamine transporters permanently expressed in cell lines.

  1998cites this paper
• Distribution of dopamine transporters in basal ganglia of cerebellar ataxic mice by [125I]RTI-121 quantitative autoradiography.

  1998cites this paper
• Pharmacology of Cocaine

  1998cites this paper
• Highly selective, novel analogs of 4-[2-(diphenylmethoxy)ethyl]- 1-benzylpiperidine for the dopamine transporter: effect of different aromatic substitutions on their affinity and selectivity.

  1997cites this paper
• Direct approach for attenuating cocaine's effects on extracellular dopamine: Targeting the dopamine transporter

  1997cites this paper
• Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease.

  1997cites this paper
• A technetium-99m SPECT imaging agent which targets the dopamine transporter in primate brain.

  1997cites this paper
• Synthesis and ligand binding studies of 4'-iodobenzoyl esters of tropanes and piperidines at the dopamine transporter.

  1997cites this paper
• Turnover of Rat Dopamine Transporter Protein in rDAT-LLC-PK1 Cells

  1997cites this paper
• Measurement of the dopaminergic degeneration in Parkinson’s disease with [123I]β-CIT and SPECT

  1997cites this paper
• SPET investigations in extrapyramidal diseases using specific ligands

  1997cites this paper
• SPECT imaging of dopamine transporter sites in normal and MPTP-Treated rhesus monkeys.

  1997cites this paper
• A simple probe measures the pharmacokinetics of[125I]RTI-55 in mouse brain in vivo.

  1997cites this paper